4//SEC Filing
DOYLE WILLIAM F 4
Accession 0001645113-22-000071
CIK 0001645113other
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 4:44 PM ET
Size
5.0 KB
Accession
0001645113-22-000071
Insider Transaction Report
Form 4
NovoCure LtdNVCR
DOYLE WILLIAM F
Director10% Owner
Transactions
- Sale
Ordinary Shares
2022-08-02$69.66/sh−837$58,305→ 551,176 total
Footnotes (1)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Documents
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001194459
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 4:44 PM ET
- Size
- 5.0 KB